A new novel by the Pulitzer Prize-winning author of "March" reinterprets the life of King David as he journeys from humble origins to become the slayer of Goliath and the ruler of a kingdom.
An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.
- Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
- Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
- Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
Most Recent Shows
Another mass shooting, this time at a community college in Oregon, has prompted new calls to change gun laws. We look at the realities of ending the cycle of gun violence in the U.S.
Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.
Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.